scholarly journals Totally Thoracoscopic Redo Mitral Valve Replacement for a High-Risk Patient Following Failed MitraClip Procedure

2021 ◽  
Vol 24 (5) ◽  
pp. E898-E900
Author(s):  
Peijian ◽  
Weitao Zhuang ◽  
Yanjun Liu ◽  
Jiexu Ma ◽  
Wei Zhu ◽  
...  
Keyword(s):  
High Risk ◽  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Heart Surgery ◽  
Surgical Intervention ◽  
Open Heart Surgery ◽  
High Risk Patient ◽  
Risk Patient ◽  
Open Heart

The wide adoption of the MitraClip procedure in clinical practice inevitably causes increases in surgical intervention demand for patients following failed MitraClip implantation. Current reports about surgical intervention after failed MitraClip procedure focused on open-heart surgery. In this case, totally thoracoscopic third-time redo mitral valve replacement was successfully performed for a high-risk patient, following aortic valve replacement and a failed MitraClip procedure.

Open heart surgery with mitral valve replacement - ordeal of an undiagnosed haemophilia patient.

2003 ◽  
Vol 25 (2) ◽  
pp. 131-133 ◽  
Author(s):  
K. Ghosh ◽  
M. Madkaikar ◽  
F. Jijina ◽  
S. Gandhi ◽  
S. Shetty ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Heart Surgery ◽  
Open Heart Surgery ◽  
Open Heart

scholarly journals Simultaneous transapical transcatheter aortic and mitral valve replacement in a high-risk patient with a previous mitral bioprosthesis

2012 ◽  
Vol 144 (3) ◽  
pp. e90-e91 ◽  
Author(s):  
Adil H. Al Kindi ◽  
Khaled F. Salhab ◽  
Samir Kapadia ◽  
Eric E. Roselli ◽  
Amar Krishnaswamy ◽  
...  
Keyword(s):  
High Risk ◽  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
High Risk Patient ◽  
Risk Patient ◽  
Mitral Bioprosthesis

scholarly journals Central venous catheters retention in a patient with mitral valve replacement: a case report

2021 ◽  
Vol 1 (1) ◽  
pp. 16-18
Author(s):  
Ngurah Dwiky Abadi Resta ◽  
I Nyoman Semadi ◽  
I Komang Adhi Parama Harta ◽  
I Wayan Sudarma ◽  
Ketut Putu Yasa
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Heart Surgery ◽  
Superior Vena ◽  
Open Heart Surgery ◽  
Vena Cava ◽  
Central Venous Catheters ◽  
Open Heart ◽  
Central Venous

Background: Retention of central venous catheters (CVC) is one complication that may occur when open-heart surgery is performed (such as mitral valve replacement). In this case report, we describe case retention of CVC in a patient with Mitral Valve Replacement (MVR) related to sutured of Superior Vena Cava (SVC) wall on cannulation site. Case Presentation:  A 15-year-old boy was admitted to Sanglah Hospital with a history of Heart failure with severe regurgitation of the mitral valve, severe tricuspid regurgitation, and left ventricular dysfunction due to rheumatic heart disease. Mitral valve replacement, tricuspid valve repair and left atrial reduction was performed. After five days of postoperative observation, the CVC could be removed. However, there is resistance when removing the catheter. After diagnostic examination, it was found that the CVC was sutured to the superior vena cava wall. The patient was then scheduled for a redo sternotomy to evacuate the CVC. The patient was discharged seven days after redo sternotomy was performed without any further postoperative complications. Conclusions: Retention of CVC during open-heart surgery is one complication that increases the risk for morbidity or mortality to the patient after heart surgery.

scholarly journals The path of the first female surgeon to open-heart surgery - Nina Starr Braunwald

2021 ◽  
Vol 0 (Ahead of Print) ◽  
Author(s):  
Zairbek Syrgaev
Keyword(s):  
Mitral Valve ◽  
Thoracic Surgery ◽  
Key Words ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Heart Surgery ◽  
Open Heart Surgery ◽  
Open Heart ◽  
Historical Note

Nina Starr Braunwald - first female heart surgeon, a pioneer in cardio-thoracic surgery, certified by the American Board of Thoracic Surgery and the first elected to the American Thoracic Surgery Association, a wonderful wife and mother of three daughters, teacher and mentor of several generations of doctors. We will tell everyone about this in more detail in our historical note Key words: female, heart surgeon; Braunwald-Morrow mitral valve, Braunwald-Cutter valve, mitral valve replacement

A Case of Successful Treatment of Infective Endocarditis Complicated with Intracranial Hemorrhage, and Literature Review

2015 ◽  
Vol 18 (5) ◽  
pp. 198
Author(s):  
Xu Yong ◽  
Zheng Weiliang ◽  
Chen Yili ◽  
Zhao Lili
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Literature Review ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Intracranial Hemorrhage ◽  
Heart Surgery ◽  
Open Heart Surgery ◽  
Optimal Timing ◽  
Open Heart

The risks of neurological deteriorations during open heart surgery under heparinization in patients with infective endocarditis complicated by intracranial hemorrhage remain unknown. The optimal timing for heart surgery is still a point of conflict. We report a case in which a young man who had suffered from infective endocarditis complicated with intracranial hemorrhage successfully received mitral valve replacement on day 9 after the onset of intracranial hemorrhage.

scholarly journals Early results of a real-world series with two transapical transcatheter mitral valve replacement devices

2020 ◽  
Author(s):  
S. Ludwig ◽  
D. Kalbacher ◽  
N. Schofer ◽  
A. Schäfer ◽  
B. Koell ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Heart Surgery ◽  
Open Heart Surgery ◽  
Functional Improvement ◽  
Study Cohort ◽  
Early Results ◽  
Transcatheter Mitral Valve Replacement

Abstract Aims Transcatheter mitral valve replacement (TMVR) with dedicated devices promises to fill the treatment gap between open-heart surgery and edge-to-edge repair for patients with severe mitral regurgitation (MR). We herein present a single-centre experience of a TMVR series with two transapical devices. Methods and results A total of 11 patients were treated with the Tendyne™ (N = 7) or the Tiara™ TMVR systems (N = 4) from 2016 to 2020 either as compassionate-use procedures or as commercial implants. Clinical and echocardiographic data were collected at baseline, discharge and follow-up and are presented in accordance with the Mitral Valve Academic Research Consortium (MVARC) definitions. The study cohort [age 77 years (73, 84); 27.3% male] presented with primary (N = 4), secondary (N = 5) or mixed (N = 2) MR etiology. Patients were symptomatic (all NYHA III/IV) and at high surgical risk [logEuroSCORE II 8.1% (4.0, 17.4)]. Rates of impaired RV function (72.7%), severe pulmonary hypertension (27.3%), moderate or severe tricuspid regurgitation (63.6%) and prior aortic valve replacement (63.6%) were high. Severe mitral annulus calcification was present in two patients. Technical success was achieved in all patients. In 90.9% (N = 10) MR was completely eliminated (i.e. no or trace MR). Procedural and 30-day mortality were 0.0%. At follow-up NYHA class was I/II in the majority of patients. Overall mortality after 3 and 6 months was 10.0% and 22.2%. Conclusions TMVR was performed successfully in these selected patients with complete elimination of MR in the majority of patients. Short-term mortality was low and most patients experienced persisting functional improvement. Graphic abstract

scholarly journals Case report of successful low-dose, ultra-slow infusion thrombolysis of prosthetic mitral valve thrombosis in a high risk patient after redo-mitral valve replacement

2020 ◽  
Vol 4 (3) ◽  
pp. 1-5
Author(s):  
Ioannis Kapos ◽  
Tobias Fuchs ◽  
Felix C Tanner
Keyword(s):  
High Risk ◽  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Prosthetic Valve ◽  
Low Dose ◽  
Therapeutic Option ◽  
High Risk Patient ◽  
Normal Dose ◽  
Valve Thrombosis

Abstract Background An increase in transvalvular pressure gradient of prosthetic valve should always raise suspicion for obstructive valve thrombosis. A multimodality diagnostic approach including transthoracic echocardiography, transoesophageal echocardiography (TOE), cinefluoroscopy, or computed tomography (CT) is necessary for a prompt diagnosis. The management of mechanical prosthetic valve thrombosis (PVT) is high risk in any therapeutic option taken. Emergency valve replacement is recommended for critically ill patients. Fibrinolysis is an alternative for patients with contraindication to surgery or if surgery is not immediately available. Case summary A 52-year-old woman presented with symptoms and signs of cardiac congestion. On laboratory, brain natriuretic peptide was elevated and international normalized ratio (INR) was in subtherapeutic range. She underwent a mitral valve replacement with mechanical prosthesis 7 months before, because of a significant residual regurgitation after repair on the same year. TOE revealed severe stenosis of the prosthesis with immobile anterior disc but there was no mass present. CT revealed a minor lesion at the hinge points of the prosthesis without involvement of the ring, suggestive for thrombus. The initial fruitless management with intravenous (i.v) heparin in high therapeutic range was followed by a successful ‘low-dose, ultra-slow’ fibrinolysis. Discussion CT may help differentiate thrombus vs. pannus. The acute onset of symptoms, inadequate anticoagulation, and restricted leaflet motion increased the suspicion for PVT. The current European guidelines propose normal dose fibrinolysis. We performed ‘low-dose, ultra-slow’ fibrinolysis due to lower bleeding risk with successful results. Low dose should be considered as alternative to normal dose fibrinolysis or urgent surgery.

scholarly journals Transcatheter Self-expandable Aortic Valve (Portico) Implantation in a Patient with Previous Mitral Valve Replacement: A Case Report

2019 ◽  
Author(s):  
Ahmet Korkmaz ◽  
Havva Tuğba Gürsoy ◽  
Mehmet İleri ◽  
Özgül Uçar Elalmış ◽  
Ümit Güray
Keyword(s):  
Case Report ◽  
Mitral Valve ◽  
Aortic Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Heart Surgery ◽  
Severe Aortic Stenosis ◽  
Open Heart Surgery ◽  
Mitral Valve Surgery ◽  
Transcatheter Aortic Valve

Transcatheter aortic valve implantation (TAVI) has shown favorable outcomes in patients with severe symptomatic aortic valve stenosis who are at high surgical risk or who are unsuitable candidates for open-heart surgery. However, concerns exist over treating patients who have undergone previous mitral valve surgery due to the potential interference between the mitral prosthetic valve or ring and the TAVI device. In this case report, we present a case in which a patient with symptomatic severe aortic stenosis and previous mechanical mitral valve replacement was successfully treated with TAVI using a Portico valve, which is under-researched.   J Teh Univ Heart Ctr 2019;14(2):85-89   This paper should be cited as: Korkmaz A, Gürsoy HT, İleri M, Uçar Elalmış Ö, Güray Ü. Transcatheter Self-expandable Aortic Valve (Portico) Implantation in a Patient with Previous Mitral Valve Replacement: A Case Report. J Teh Univ Heart Ctr 2019;14(2):85-89.

Sign in / Sign up

Export Citation Format

Share Document